Purple glove syndrome (PGS) is a rare complication of intravenous phenytoin use that typically presents with pain, edema, and discoloration at the injection site that spreads to the distal limb. Several risk factors have been associated with the development of PGS; however, the etiology remains unknown. We present a case of PGS and briefly review the current understanding of this syndrome.
MacCara MEExtravasation: a hazard of intravenous therapy. Drug Intell Clin Pharm1983; 17: 713—17.
4.
Spengler RF, Arrowsmith JB, Kilarski DJ, Buchanan C., von Behren L., Graham DRSevere soft-tissue injury following intravenous infusion of phenytoin. Patient and drug administration risk factors. Arch Intern Med1988; 148: 1329—33.
5.
Ten Holder SM , Joy MS, Falk RJCutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother2002; 36: 130—47.
6.
Snelson C., Dieckman B.Recognizing and managing purple glove syndrome. Crit Care Nurse2000; 20: 54—61.
7.
Hanna DRPurple glove syndrome: a complication of intravenous phenytoin. J Neurosci Nurs1992; 24: 340—45.
8.
Yoshikawa H., Abe T., Oda Y.Purple glove syndrome caused by oral administration of phenytoin. J Child Neurol2000; 15: 762.
9.
O'Brien TJ, Cascino GD, So EL, Hanna DRIncidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin. Neurology1998; 51: 1034—39.
10.
Touchette DR , Rhoney DHCost-minimization analysis of phenytoin and fosphenytoin in the emergency department. Pharmacotherapy2000; 20: 908—16.
